Thus, therapeutic approaches targeting eIF3f‐PHGDH axis represent an attractive strategy for eIF3f‐overexpressing CRC patients and further developing compounds that suppress eIF3f‐mediated PHGDH stabilization and inhibit Wnt signals are worthy of more investigation. Here, EIF3F is linked to colorectal carcinoma.